C Alam1, S Valkonen, S Ohls, K Törnqvist, A Hänninen. 1. Department of Medical Microbiology and Immunology, University of Turku, Kiinamyllynkatu 13, 20520 Turku, Finland. catharina.alam@utu.fi
Abstract
AIMS/HYPOTHESIS: NOD.Igmicro ( null ) mice lacking mature B cells are highly resistant to diabetes and display poor CD4 T cell responses to autoantigens. Nevertheless, the degree to which different B cell subsets contribute to diabetes in NOD mice remains unresolved. Due to their role in the recognition of microbial and autoantigens, peritoneal B cell characteristics were examined in NOD mice to see if they differ developmentally, phenotypically or functionally in aspects relevant to diabetogenesis. METHODS: The population dynamics, activation state, migratory behaviour and antigen presentation function were investigated in NOD peritoneal B cells. RESULTS: NOD peritoneal B cells were found to express abnormally high levels of co-stimulatory molecules (CD40, CD86 and CD69). In contrast, the expression of L-selectin and integrin alpha4beta1 was markedly reduced in NOD mice compared with BALB/c and C57BL/6 mice. The number of B cells in the peritoneum was lower in NOD than in control mice throughout development; migration of B cells from the peritoneum to the pancreatic lymph nodes in NOD mice was enhanced tenfold. NOD B cells showed no chemotactic response to sphingosine-1-phosphate, which normally acts to retain B cells in the peritoneum. Peritoneal B cells of NOD mice also presented insulin autoantigen to CD4 T cells, inducing T cell proliferation. CONCLUSIONS/ INTERPRETATION: NOD peritoneal B cells are hyperactivated, migrate to the pancreatic lymph nodes and are capable of driving insulin-specific CD4 T cell activation. These characteristics could make them important for inducing or amplifying T cell responses against islet-antigens.
AIMS/HYPOTHESIS: NOD.Igmicro ( null ) mice lacking mature B cells are highly resistant to diabetes and display poor CD4 T cell responses to autoantigens. Nevertheless, the degree to which different B cell subsets contribute to diabetes in NOD mice remains unresolved. Due to their role in the recognition of microbial and autoantigens, peritoneal B cell characteristics were examined in NOD mice to see if they differ developmentally, phenotypically or functionally in aspects relevant to diabetogenesis. METHODS: The population dynamics, activation state, migratory behaviour and antigen presentation function were investigated in NOD peritoneal B cells. RESULTS: NOD peritoneal B cells were found to express abnormally high levels of co-stimulatory molecules (CD40, CD86 and CD69). In contrast, the expression of L-selectin and integrin alpha4beta1 was markedly reduced in NOD mice compared with BALB/c and C57BL/6 mice. The number of B cells in the peritoneum was lower in NOD than in control mice throughout development; migration of B cells from the peritoneum to the pancreatic lymph nodes in NOD mice was enhanced tenfold. NOD B cells showed no chemotactic response to sphingosine-1-phosphate, which normally acts to retain B cells in the peritoneum. Peritoneal B cells of NOD mice also presented insulin autoantigen to CD4 T cells, inducing T cell proliferation. CONCLUSIONS/ INTERPRETATION: NOD peritoneal B cells are hyperactivated, migrate to the pancreatic lymph nodes and are capable of driving insulin-specific CD4 T cell activation. These characteristics could make them important for inducing or amplifying T cell responses against islet-antigens.
Authors: Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist Journal: Biochem J Date: 2006-09-15 Impact factor: 3.857
Authors: Maria Carmen Puertas; Jorge Carrillo; Xavier Pastor; Rosa Maria Ampudia; Aurora Alba; Raquel Planas; Ricardo Pujol-Borrell; Marta Vives-Pi; Joan Verdaguer Journal: Diabetes Date: 2007-04 Impact factor: 9.461
Authors: Eliver Eid Bou Ghosn; Yang Yang; James Tung; Leonard A Herzenberg; Leonore A Herzenberg Journal: Proc Natl Acad Sci U S A Date: 2008-03-28 Impact factor: 11.205
Authors: Paul J Grippo; Palamadai N Venkatasubramanian; Richard H Knop; Daniel M Heiferman; Gheorghe Iordanescu; Laleh G Melstrom; Kevin Adrian; Morgan R Barron; David J Bentrem; Alice M Wyrwicz Journal: Am J Pathol Date: 2011-05-31 Impact factor: 4.307
Authors: R Emani; M N Asghar; R Toivonen; L Lauren; M Söderström; D M Toivola; E A F van Tol; A Hänninen Journal: Diabetologia Date: 2013-06-08 Impact factor: 10.122
Authors: C Alam; E Bittoun; D Bhagwat; S Valkonen; A Saari; U Jaakkola; E Eerola; P Huovinen; A Hänninen Journal: Diabetologia Date: 2011-03-05 Impact factor: 10.122
Authors: Catharina Alam; Suvi Valkonen; Vindhya Palagani; Jari Jalava; Erkki Eerola; Arno Hänninen Journal: Diabetes Date: 2010-06-14 Impact factor: 9.461